BERGMANN ANTHONY (Chief Financial Officer) sold 68.2% of their position (24.10K shares) of CAPRICOR THERAPEUTICS, INC. on the open market
Open‑market sale worth $732.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/30/2026ACC: 0001593087-26-000013
Officer· Chief Financial Officer
Since Aug 2019
-24.10K
Net shares
Net seller
$732.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
24.10K acquired · 48.20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24.10K
Price / share
$3.18
Trade value
$76.64K
% of position
214.7%
6/25/2026
11.22K→35.32K
Common Stock
Direct
Shares
−24.10K
Price / share
$30.38
Trade value
$732.16K
% of position
68.2%
6/25/2026
35.32K→11.22K
Total
Net shares
+0.00
Net value
-$655.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2026 | M · Option Exercise | +24.10K | $3.18 | $76.64K | 214.7% | 11.22K | 35.32K |
| Common Stock Direct | 6/25/2026 | S · Sale | −24.10K | $30.38 | $732.16K | 68.2% | 35.32K | 11.22K |
| Total | +0.00 | -$655.52K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
24.10K shares
Shares
−24.10K
Strike price
3.18
Held after
91.98K
Exercisable
—
6/25/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock24.10K shares | 6/25/2026 | M · Option Exercise | −24.10K | 3.18 | — | 91.98K |